Lipid Lowering Drugs: Present Status and Future Developments.

Ruscica, Massimiliano; Ferri, Nicola; Santos, Raul D; Sirtori, Cesare R; Corsini, Alberto

Ruscica, Massimiliano; Ferri, Nicola; Santos, Raul D; Sirtori, Cesare R; Corsini, Alberto.

Affiliation

Ruscica M; Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy. massimiliano.ruscica@unimi.it.
Ferri N; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy.
Santos RD; Lipid Clinic, Heart Institute (InCor), University of Sao Paulo, São Paulo, Brazil.
Sirtori CR; Hospital Israelita Albert Einstein, São Paulo, Brazil.
Corsini A; Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.

Curr Atheroscler Rep ; 23(5): 17, 2021 03 10.

Article in En | MEDLINE | ID: mdl-33694108

Subject(s)

Anticholesteremic Agents; Hypercholesterolemia/drug therapy; Hypertriglyceridemia/drug therapy; Cholesterol, LDL; Humans; Lipids; Lipoprotein(a); Proprotein Convertase 9

Key words

ANGPTL3LRX; APOCIII-LRx; Inclisiran; Lipoprotein(a); Proprotein convertase subtilisin/kexin type 9

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertriglyceridemia / Hypercholesterolemia / Anticholesteremic Agents Limits: Humans Language: En Journal: Curr Atheroscler Rep Journal subject: ANGIOLOGIA Year: 2021 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google